RecruitingAtopic DermatitisAtopic Dermatitis EczemaEczema
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Eligible age
18–74 yrs
Accepts
All genders
Locations
11 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of this study is to evaluate the efficacy and safety of different dose regimens of IMG-007, compared to placebo.
Sponsor: Inmagene LLC
Where it's recruiting
California
Lancaster · Los Angeles
Florida
Ocala · Tampa
Illinois
Rolling Meadows
New York
Kew Gardens · New York · Woodbury
North Carolina
Charlotte
North Dakota
Fargo
Ohio
Columbus · Mayfield Heights
Oregon
Portland
South Carolina
Anderson
Texas
Southlake
Washington
Burien
Source: ClinicalTrials.gov · NCT07037901 · last updated 2026-05-27